Pedro Karlo M, Alvi Mohammed Ali, Hejrati Nader, Moghaddamjou Ali, Fehlings Michael G
Division of Neurosurgery and Spine Program, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.
Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.
Neurosurgery. 2024 Jan 10. doi: 10.1227/neu.0000000000002818.
We assessed the relationship between Modified Frailty Index-5 (mFI-5) and neurological outcomes, as well as health-related quality of life (HRQoL) measures, in elderly patients with degenerative cervical myelopathy (DCM) after surgery.
Data from 3 major DCM trials (the Arbeitsgemeinschaft für Osteosynthesefragen Spine Cervical Spondylotic Myelopathy-North America, Cervical Spondylotic Myelopathy-International, and CSM-PROTECT studies) were combined, involving 1047 subjects with moderate to severe myelopathy. Patients older than 60 years with 6-month and 1-year postoperative data were analyzed. Neurological outcome was assessed using the modified Japanese Orthopaedic Association score, while HRQoL was measured using the 36-Item Short Form Health Survey (SF-36) (both Physical Component Summary [SF-36 PCS] and Mental Component Summary [SF-36 MCS] scores) and the Neck Disability Index. Frail (mFI ≥2) and nonfrail (mFI = 0-1) cohorts were compared using univariate paired statistics.
The final analysis included 261 patients (62.5% male), with a mean age of 71 years (95% CI 70.7-72). Frail patients (mFI ≥2) had lower baseline modified Japanese Orthopaedic Association scores (10.45 vs 11.96, P < .001), SF-36 PCS scores (32.01 vs 36.51, P < .001), and SF-36 MCS scores (39.32 vs 45.24, P < .001). At 6-month follow-up, SF-36 MCS improved by a mean (SD) of 7.19 (12.89) points in frail vs 2.91 (11.11) points in the nonfrail group (P = .016). At 1 year after surgery, frail patients showed greater improvement in both SF-36 PCS and SF-36 MCS composite scores compared with nonfrail patients (7.81 vs 4.49, P = .038, and 7.93 vs 3.01, P = .007, respectively). Bivariate regression analysis revealed that higher mFI-5 scores correlated with more substantial improvement in overall mental status at 6 months and 1 year (P = .024 and P = .009, respectively).
mFI-5 is a clinically helpful signature to reflect the HRQoL status among elderly patients with DCM. Despite preoperative medical frailty, elderly patients with DCM experience significant HRQoL improvement after surgery. These findings enable clinicians to identify elderly patients with modifiable comorbidities and provide informed counseling on anticipated outcomes.
II.
我们评估了改良衰弱指数-5(mFI-5)与老年退行性颈椎病(DCM)患者术后神经功能结局以及健康相关生活质量(HRQoL)指标之间的关系。
合并了3项主要的DCM试验(德国骨科学会脊柱颈椎病北美研究、颈椎病国际研究和CSM-PROTECT研究)的数据,涉及1047例中重度脊髓病患者。对年龄大于60岁且有术后6个月和1年数据的患者进行分析。使用改良日本骨科协会评分评估神经功能结局,同时使用36项简明健康调查(SF-36)(包括躯体健康评分[SF-36 PCS]和心理健康评分[SF-36 MCS])及颈部功能障碍指数测量HRQoL。使用单变量配对统计方法比较衰弱(mFI≥2)和非衰弱(mFI = 0-1)队列。
最终分析纳入261例患者(62.5%为男性),平均年龄71岁(95%CI 70.7-72)。衰弱患者(mFI≥2)的基线改良日本骨科协会评分较低(10.45对11.96,P <.001),SF-36 PCS评分较低(32.01对36.51,P <.001),SF-36 MCS评分较低(39.32对45.24,P <.001)。在6个月随访时,衰弱组的SF-36 MCS平均(标准差)改善7.19(12.89)分,而非衰弱组改善2.91(11.11)分(P = 0.016)。术后1年,与非衰弱患者相比,衰弱患者的SF-36 PCS和SF-36 MCS综合评分改善更大(分别为7.81对4.49,P = 0.038;7.93对3.01,P = 0.007)。双变量回归分析显示,较高的mFI-5评分与6个月和1年时整体精神状态的更显著改善相关(分别为P = 0.024和P = 0.009)。
mFI-具有临床参考价值,可反映老年DCM患者的HRQoL状况。尽管术前存在医学衰弱,但老年DCM患者术后HRQoL仍有显著改善。这些发现使临床医生能够识别具有可改变合并症的老年患者,并就预期结果提供充分的咨询。
II级。